Literature DB >> 23474760

Regulation of cell migration, invasion and metastasis by IAP proteins and their antagonists.

S Fulda1.   

Abstract

Inhibitor of apoptosis (IAP) proteins are a family comprised of a total of eight mammalian members that were initially described to act as endogenous inhibitors of caspases. In addition, extensive evidence has been accumulated over the last years showing that IAP proteins can regulate various signal transduction pathways, thereby exerting non-apoptotic functions beyond the inhibition of apoptosis. For example, IAP proteins have been implied in the control of cell motility, migration, invasion and metastasis. However, currently the question is controversially discussed whether or not they positively or negatively control these processes. As small-molecule inhibitors of IAP proteins have entered the stage of clinical evaluation as experimental cancer therapeutics, a better understanding of their various cellular effects will be critical for their rational use in the treatment of human diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474760     DOI: 10.1038/onc.2013.63

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Clinicopathological and functional implications of the inhibitor of apoptosis proteins survivin and XIAP in esophageal cancer.

Authors:  Levent Dizdar; Lisa M Jünemann; Thomas A Werner; Pablo E Verde; Stephan E Baldus; Nikolas H Stoecklein; Wolfram T Knoefel; Andreas Krieg
Journal:  Oncol Lett       Date:  2018-01-09       Impact factor: 2.967

Review 2.  Survivin - The inconvenient IAP.

Authors:  Dario C Altieri
Journal:  Semin Cell Dev Biol       Date:  2015-01-12       Impact factor: 7.727

3.  Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion.

Authors:  Dayana B Rivadeneira; M Cecilia Caino; Jae Ho Seo; Alessia Angelin; Douglas C Wallace; Lucia R Languino; Dario C Altieri
Journal:  Sci Signal       Date:  2015-08-11       Impact factor: 8.192

4.  WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1.

Authors:  Yi-Fang Chang; Ya-Fen Hsu; Pei-Ting Chiu; Wei-Jan Huang; Shiu-Wen Huang; George Ou; Joen-Rong Sheu; Ming-Jen Hsu
Journal:  Oncotarget       Date:  2015-01-01

5.  A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cells.

Authors:  S-H Lee; J-Y Lee; C L Jung; I H Bae; K H Suh; Y G Ahn; D-H Jin; T W Kim; Y-A Suh; S J Jang
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

6.  Regulation of cancer stem-like cell differentiation by Smac mimetics.

Authors:  Simone Fulda
Journal:  Mol Cell Oncol       Date:  2014-10-29

Review 7.  Caspase-dependent non-apoptotic processes in development.

Authors:  Yu-Ichiro Nakajima; Erina Kuranaga
Journal:  Cell Death Differ       Date:  2017-05-19       Impact factor: 15.828

Review 8.  IAP proteins as targets for drug development in oncology.

Authors:  Laurence Dubrez; Jean Berthelet; Valérie Glorian
Journal:  Onco Targets Ther       Date:  2013-09-16       Impact factor: 4.147

9.  Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner.

Authors:  Carina Lindemann; Viola Marschall; Andreas Weigert; Thomas Klingebiel; Simone Fulda
Journal:  Neoplasia       Date:  2015-06       Impact factor: 5.715

10.  Investigating isoquinoline derivatives for inhibition of inhibitor of apoptosis proteins for ovarian cancer treatment.

Authors:  Chen Chen; Jie Wu; Pengfei Zhu; Congjian Xu; Liangqing Yao
Journal:  Drug Des Devel Ther       Date:  2017-09-11       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.